The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Further evaluations of nivolumab (nivo) versus investigator’s choice (IC) chemotherapy for recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): CheckMate 141.
 
Robert L. Ferris
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; Merck; Ono Pharmaceutical
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; VentiRx
 
George R. Blumenschein
Consulting or Advisory Role - Abbvie; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Merck
Research Funding - AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Merck; Novartis; Xcovery
 
Jerome Fayette
Leadership - Glycotope GmbH
 
Joel Guigay
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MERCK SERONO (Inst)
 
A. Dimitrios Colevas
Stock and Other Ownership Interests - Gilead Sciences; Pharmacyclics
Research Funding - Bristol-Myers Squibb; Curis; Genentech
 
Lisa F. Licitra
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Debiopharm Group; Eisai; GlaxoSmithKline; Merck Serono; MSD; Novartis; SOBI; VentiRx
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Exelixis (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; Celgene; Debiopharm Group; Merck Serono; MSD; sobi
 
Kevin J. Harrington
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Amgen; AstraZeneca; Merck
 
Stefan Kasper
No Relationships to Disclose
 
Everett E. Vokes
Stock and Other Ownership Interests - McKesson
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Celgene; Clovis Oncology; Eisai; GeneCentric; Genentech; Lilly; Merck; Synta; Transgene; VentiRx
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Celgene; Clovis Oncology; Eisai; GeneCentric; Genentech; Lilly; Merck; Synta; Transgene; VentiRx
 
Caroline Even
No Relationships to Disclose
 
Francis P. Worden
Honoraria - Bayer
Consulting or Advisory Role - Bayer/Onyx
Travel, Accommodations, Expenses - Bayer/Onyx
 
Robert I. Haddad
Consulting or Advisory Role - Bayer; Celgene; Eisai; Merck
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst)
 
Naomi Kiyota
Honoraria - Eisai
Research Funding - Boehringer Ingelheim; Eisai; Ono Pharmaceutical
 
Makoto Tahara
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Merck Serono; Otsuka
Consulting or Advisory Role - Bayer; MSD; Ono Pharmaceutical; Pfizer
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Merck Sharp & Dohme (Inst); NanoCarrier (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst)
 
Manish Monga
Employment - Bristol-Myers Squibb
 
Mark John Lynch
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
William J. Geese
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Justin Kopit
Employment - Bristol-Myers Squibb
 
James W Shaw
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Maura L. Gillison
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck